Last update July 16, 2017
Very Low Risk
We do not have alternatives for Peginterferon alfa-2a since it is relatively safe.
Suggestions made at e-lactancia are done by APILAM team of health professionals, and are based on updated scientific publications. It is not intended to replace the relationship you have with your doctor but to compound it. The pharmaceutical industry contraindicates breastfeeding, mistakenly and without scientific reasons, in most of the drug data sheets.
Your contribution is essential for this service to continue to exist. We need the generosity of people like you who believe in the benefits of breastfeeding.
Thank you for helping to protect and promote breastfeeding.
Peginterferon alfa-2a is also known as Peginterferon alfa. Here it is a list of alternative known names::
Peginterferon alfa-2a belongs to this group or family:
Main tradenames from several countries containing Peginterferon alfa-2a in its composition:
Variable | Value | Unit |
---|---|---|
Oral Bioavail. | 0 | % |
Molecular weight | 30.000 - 60.000 | daltons |
VD | 0.1 - 0.2 | l/Kg |
Tmax | 72 - 96 | hours |
T½ | 60 - 160 | hours |
Write us at elactancia.org@gmail.com
e-lactancia is a resource recommended by AELAMA of Spain
Would you like to recommend the use of e-lactancia? Write to us at corporate mail of APILAM
It is used in the treatment of leukemia, and, hepatitis B and C.
Breast milk contains several interferon-like substances which contribute to its anti-viral action.
High molecular weight of interferon accounts for its small secretion into breast milk. A minimal gastrointestinal absorption is commonly accepted.
American Academy of Pediatrics: Maternal Medication Usually Compatible With Breastfeeding.
See below the information of this related product: